Rosemarie Ingleton, MD
Dermatology · New York, NYNPI 1366414567
Payments from drug & device makers
What this record shows
This record is dominated by other: $20,628 of the $26,686 with a category attached, or 77.3%. Kaleo, Inc. accounts for 77.3% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2021 at $22,225 and has fallen 97.5% since, to $564 in 2025.
Across 209 payments — averaging $127.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kaleo, Inc.$21K
- AbbVie$3K
- Galderma Laboratories, L.p.$700
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$385
- Amgen$345
- Pfizer$288
- plus $2K from 18 others
What the payments were for
- Food & beverage$6,04023%
- Education$180%
- Other$20,62877%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kaleo, Inc. | 1 | $20,628 |
| AbbVie(2 entities) | 80 | $2,569 |
| Galderma Laboratories, L.p. | 24 | $700 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 22 | $385 |
| Amgen | 8 | $345 |
| Pfizer | 6 | $288 |
| Sun Pharmaceutical Industries Inc. | 13 | $249 |
| Regeneron Healthcare Solutions, Inc. | 9 | $238 |
| Merz North America, Inc. | 2 | $167 |
| Sanofi | 3 | $163 |
| Incyte Corporation | 7 | $153 |
| Almirall LLC | 7 | $148 |
| Bristol Myers Squibb | 2 | $148 |
| LEO Pharma Inc. | 6 | $123 |
| EPI Health, LLC | 4 | $80 |
| Johnson & Johnson | 3 | $69 |
| Lilly USA, LLC | 2 | $47 |
| VYNE Pharmaceuticals Inc. | 2 | $43 |
| Mission Pharmacal Company | 2 | $30 |
| Promius Pharma LLC | 1 | $28 |
| Journey Medical Corporation | 2 | $23 |
| Aclaris Therapeutics, Inc. | 1 | $23 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Mayne Pharma Commercial LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,686 in reported general payments places this provider in the 85th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 15 | $1,126 |
| Clobetasol Propionate | 18 | $942 |
| Ketoconazole | 40 | $546 |
| ValacyclovirValacyclovir Hcl | 15 | $365 |
| Doxycycline Hyclate | 11 | $214 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $124 |
| Hydrocortisone | 18 | $98 |
| Triamcinolone Acetonide | 12 | $82 |
| Minoxidil | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.